Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Jazz Pharmaceuticals to buy Chimerix for $935 million
07:14am, Wednesday, 05'th Mar 2025
Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its experimental drug to treat a rare brain tumor, the companies said on Wednesday.
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
07:00am, Wednesday, 05'th Mar 2025
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors- - Transaction to add near-term commercial opportunity to Jazz's pipeline- -Transaction repre
5 Stocks With Recent Price Strength Defying a Weak February
08:31am, Tuesday, 04'th Mar 2025
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are EVER, JAZZ, PGR, SONY, NWG.
Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
01:20pm, Monday, 03'rd Mar 2025
Jazz (JAZZ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
11:00am, Monday, 03'rd Mar 2025
The consensus price target hints at a 29.6% upside potential for Jazz (JAZZ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate rev
Best Momentum Stocks to Buy for March 3rd
11:00am, Monday, 03'rd Mar 2025
STRL. BATRA and JAZZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 3, 2025.
4 Stocks Trading Near 52-Week High With More Upside Potential
10:46am, Monday, 03'rd Mar 2025
Stocks like NFG, ENS, TAP and JAZZ are seeing price strength and have a high chance of carrying the momentum forward.
New Strong Buy Stocks for March 3rd
08:01am, Monday, 03'rd Mar 2025
Teaser: STRL, CAPL, BATRA, CYD and JAZZ have been added to the Zacks Rank #1 (Strong Buy) List on March 3, 2025.
Best Value Stocks to Buy for March 3rd
07:10am, Monday, 03'rd Mar 2025
EME, JAZZ and STRL made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 3, 2025.
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?
10:50am, Friday, 28'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
International Markets and Jazz (JAZZ): A Deep Dive for Investors
10:15am, Friday, 28'th Feb 2025
Explore Jazz's (JAZZ) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Jazz Pharmaceuticals: Decent 2025 Outlook, Extended Timeline For Zanidatamab
03:15pm, Wednesday, 26'th Feb 2025
Jazz Pharmaceuticals ended 2024 on a strong note, beating analyst estimates, and the 2025 revenue outlook is slightly below consensus. The delay in zanidatamab's phase 3 trial results is slightly disa
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
10:45am, Wednesday, 26'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Jazz Stock Gains as Q4 Earnings & Sales Surpass Expectations
08:51am, Wednesday, 26'th Feb 2025
Jazz reports better-than-expected fourth-quarter results. Its newly issued EPS guidance of $22.50-$24.00 for full-year 2025 surpasses our expectations.
Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics
07:35pm, Tuesday, 25'th Feb 2025
While the top- and bottom-line numbers for Jazz (JAZZ) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare t
